Dozens of state attorneys general have urged Congress to ban or clarify intoxicating hemp-derived THC products, citing safety concerns and enforcement challenges. This coordinated push signals tightening regulations ahead — and rising compliance risks for hemp operators nationwide.

Colombian President Gustavo Petro publicly urged Donald Trump to legalize U.S. cannabis exports, signaling how international diplomacy and cannabis reform are becoming intertwined. The move underscores Colombia’s ambitions to lead global cannabis trade as the U.S. faces pressure to modernize its federal policies.

Missouri regulators are preparing enforcement actions against the state’s booming hemp-derived THC beverage market, which is projected to grow 25% in 2025. As federal oversight remains unclear, Missouri joins other states in tightening control to protect consumers and ensure market integrity.

Thirty-seven state attorneys general have urged Congress to ban hemp-derived THC products, citing health and enforcement concerns. Their unified call for federal action could reshape the future of hemp regulation — and impact every operator in the space.

Pennsylvania lawmakers advanced a bill to create a Cannabis Control Board that would oversee both medical marijuana and hemp-derived products. The move emphasizes regulatory reform and consumer safety, not adult-use legalization — but it could set the stage for a more unified and professional cannabis framework.

Cannabis stocks like Tilray, Canopy Growth, and Greenlane are seeing renewed investor attention thanks to increased trading volume and optimism around policy reform. Here’s what’s driving the resurgence — and what it means for the future of cannabis business and investment.

Massachusetts-based MariMed is expanding into New York through a licensing partnership with Farm 2 Hand LLC, giving it access to the state’s $6 billion adult-use cannabis market. The deal highlights the growing trend of compliance-focused brand licensing as a key strategy for national cannabis growth.

The American Council of Cannabis Medicine is partnering with insurers, health systems, and wellness organizations to expand medically guided cannabis access. This collaboration marks a major step toward integrating cannabis into mainstream healthcare and reshaping how patients receive treatment.

West Virginia’s medical cannabis program has generated nearly $34 million in taxes and fees since 2021 — yet none of it has been spent. As the state’s funds sit idle, patients and operators are left wondering when the benefits of legalization will finally reach communities in need.

Two-thirds of licensed cannabis businesses in Los Angeles owe nearly $400 million in unpaid taxes, forcing the city to consider a tax amnesty program. The shortfall exposes deeper challenges facing California’s cannabis industry — from over-taxation to compliance fatigue.

New York regulators have charged Omnium Canna with allegedly allowing unlicensed operators to manufacture and package cannabis under its license. The “rent-a-license” case exposes serious weaknesses in the state’s track-and-trace system and highlights why compliance and risk management are critical for cannabis operators.

Massachusetts cannabis advocates are fighting to keep the state’s $1.6 billion market alive as a repeal campaign gains momentum for the 2026 ballot. The outcome could redefine legalization not only in Massachusetts but across the country — and serve as a wake-up call for cannabis operators to prepare for regulatory risk.

A new lawsuit threatens to derail Florida’s adult-use cannabis initiative by challenging up to 200,000 voter signatures. As the state’s legalization campaign faces mounting legal and political hurdles, the future of recreational cannabis in Florida hangs in the balance.

Minnesota’s new cannabis retailers are facing empty shelves as supply chain bottlenecks and regulatory backlogs slow product delivery. Here’s why the shortages are happening, what lessons other states can offer, and how businesses can prepare for long-term stability.

A new synthetic cannabinoid shows strong potential in treating cachexia — the severe weight loss associated with cancer. This breakthrough could expand medical cannabis applications and reshape how cannabinoids are used in clinical care.

A new national study by MRI-Simmons reveals that 31% of U.S. adults have used cannabis in the past six months, confirming its place in mainstream wellness culture. As acceptance grows, cannabis is being redefined from a taboo topic to a trusted part of health and lifestyle — bringing new opportunities and challenges for businesses.

A federal judge in California temporarily blocked Perris from enforcing a cannabis billboard ban, ruling that the city failed to justify its restriction under the First Amendment. The case could set an important precedent for cannabis advertising rights and free commercial speech protections.

Ohio’s governor has issued a 90-day ban on intoxicating hemp-derived products, shaking up the state’s CBD and hemp market. The move highlights the growing push to regulate all THC products equally—and what businesses must do to adapt fast.

Ohio’s Senate has approved a major overhaul of marijuana DUI laws, requiring proof of actual impairment instead of relying on residual THC levels. The reform marks a shift toward science-based policy, setting a fairer and more accurate standard for cannabis enforcement.

Investor confidence is rising again as Canaccord Genuity turns bullish on U.S. cannabis stocks, citing optimism over rescheduling and federal reform. Here’s why this shift matters for operators, investors, and the broader cannabis industry.